Novogen - 20 Year Stock Price History | KZIA

Historical daily share price chart and data for Novogen since 1999 adjusted for splits. The latest closing stock price for Novogen as of June 24, 2019 is 2.42.
  • The all-time high Novogen stock price is 100.33, which is 4045.9% above the current share price.
  • The Novogen 52-week high stock price is 3.90, which is 61.2% above the current share price.
  • The Novogen 52-week low stock price is 2.20, which is 9.1% below the current share price.
  • The average Novogen stock price for the last 52 weeks is 3.13.
Novogen Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2019 3.2059 2.4500 3.9000 2.2698 2.4200 -0.41%
2018 3.9308 3.3500 6.2500 2.2026 2.4300 -23.58%
2017 4.0431 5.8400 7.1600 2.4000 3.1799 -45.74%
2016 7.8791 8.2000 11.0800 5.8400 5.8600 -29.90%
2015 14.2235 8.6400 36.9200 8.3600 8.3600 0.48%
2014 13.8010 17.2400 21.5200 6.5600 8.3200 -51.63%
2013 16.8262 4.4756 36.2000 3.7821 17.2000 285.41%
2012 1.8321 1.7658 6.5754 0.9632 4.4628 247.52%
2011 2.7707 1.7979 6.9670 1.2842 1.2842 -21.57%
2010 3.8985 8.0266 9.3750 1.3164 1.6374 -79.27%
2009 7.9891 8.6366 15.8284 4.1096 7.8981 -1.20%
2008 16.8786 17.2731 27.9324 6.2607 7.9944 -54.65%
2007 28.6345 33.2299 40.4538 16.2136 17.6263 -45.96%
2006 38.9524 58.5939 59.1076 28.1893 32.6199 -44.08%
2005 62.2464 70.7942 72.8811 56.0575 58.3370 -17.71%
2004 65.7867 87.4573 94.3923 48.4804 70.8905 -19.12%
2003 51.2524 34.8031 100.3319 24.2402 87.6500 185.57%
2002 20.7869 24.0797 30.6935 10.3703 30.6935 18.76%
2001 19.3484 25.2997 36.7295 6.3570 25.8455 2.16%
2000 35.3939 32.1062 45.7514 25.2997 25.2997 -21.20%
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.011B $0.000B
Kazia Therapeutics Limited is an oncology-focused biotechnology company. It develops anti-cancer drugs as well as provides pharmaceutical research and development technology solutions. The company's lead program is GDC-0084, a small molecule inhibitor of the PI3K / AKT / mTOR pathway, which is being developed to treat glioblastoma multiforme, the primary and most aggressive form of brain cancer. Kazia Therapeutics Limited, formerly known as Novogen Limited, is based in Sydney, Australia.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $114.125B 12.90
Gilead Sciences (GILD) United States $88.452B 10.74
Celgene (CELG) United States $69.757B 11.82
Illumina (ILMN) United States $53.149B 61.60
Vertex Pharmaceuticals (VRTX) United States $47.119B 56.96
Biogen (BIIB) United States $46.358B 8.80
Regeneron Pharmaceuticals (REGN) United States $34.997B 16.45
Alexion Pharmaceuticals (ALXN) United States $29.687B 16.80
Incyte (INCY) United States $19.021B 77.13
BioMarin Pharmaceutical (BMRN) United States $15.742B 0.00
Exact Sciences (EXAS) United States $14.936B 0.00
Seattle Genetics (SGEN) United States $11.573B 0.00
Array BioPharma (ARRY) United States $10.245B 0.00
Sarepta Therapeutics (SRPT) United States $9.631B 0.00
QIAGEN (QGEN) Netherlands $9.180B 30.16
Bio-Techne Corp (TECH) United States $7.965B 54.34
Alnylam Pharmaceuticals (ALNY) United States $7.923B 0.00
Guardant Health (GH) United States $7.707B 0.00
Bluebird Bio (BLUE) United States $6.608B 0.00
Galapagos (GLPG) Belgium $6.528B 0.00
Exelixis (EXEL) United States $6.449B 16.44
Amarin (AMRN) Ireland $6.286B 0.00
BeiGene (BGNE) Cayman Islands $5.662B 0.00
Ascendis Pharma (ASND) Denmark $5.157B 0.00
Moderna (MRNA) United States $4.836B 0.00
Blueprint Medicines (BPMC) United States $4.649B 0.00
ARGENX SE-ADR (ARGX) Netherlands $4.509B 0.00
Spark Therapeutics (ONCE) United States $4.036B 0.00
Repligen (RGEN) United States $3.922B 97.69
ACADIA Pharmaceuticals (ACAD) United States $3.748B 0.00
China Biologic Products (CBPO) China $3.739B 23.75
Mirati Therapeutics (MRTX) United States $3.657B 0.00
Ultragenyx Pharmaceutical (RARE) United States $3.598B 0.00
Global Blood Therapeutics (GBT) United States $3.554B 0.00
Alkermes (ALKS) Ireland $3.544B 0.00
Allogene Therapeutics (ALLO) United States $3.261B 0.00
MorphoSys AG Unsponsored ADR (MOR) Germany $3.163B 0.00
UniQure (QURE) Netherlands $3.107B 0.00
Amicus Therapeutics (FOLD) United States $2.855B 0.00
Arena Pharmaceuticals (ARNA) United States $2.840B 5.77
Medicines (MDCO) United States $2.690B 0.00
Lion Biotechnologies (IOVA) United States $2.669B 0.00
Reata Pharmaceuticals (RETA) United States $2.627B 0.00
Immunomedics (IMMU) United States $2.513B 0.00
Intercept Pharmaceuticals (ICPT) United States $2.424B 0.00
CRISPR Therapeutics AG (CRSP) Switzerland $2.403B 0.00
Halozyme Therapeutics (HALO) United States $2.391B 0.00
Emergent Biosolutions (EBS) United States $2.382B 20.69
Akcea Therapeutics (AKCA) United States $2.251B 0.00
NeoGenomics (NEO) United States $2.230B 146.00
Ligand Pharmaceuticals (LGND) United States $2.200B 18.22
MyoKardia (MYOK) United States $2.185B 0.00
Acceleron Pharma (XLRN) United States $2.117B 0.00
Insmed (INSM) United States $2.078B 0.00
Genomic Health (GHDX) United States $2.033B 43.18
Zai Lab Unsponsored ADR (ZLAB) China $1.963B 0.00
REGENXBIO (RGNX) United States $1.949B 0.00
Denali Therapeutics (DNLI) United States $1.920B 0.00
Allakos (ALLK) United States $1.908B 0.00
Biohaven Pharmaceutical Holding (BHVN) United States $1.828B 0.00
Audentes Therapeutics (BOLD) United States $1.789B 0.00
Myriad Genetics (MYGN) United States $1.726B 17.17
AnaptysBio (ANAB) United States $1.601B 0.00
Nabriva Therapeutics AG (NBRV) Ireland $1.540B 0.00
Apellis Pharmaceuticals (APLS) United States $1.522B 0.00
Coherus BioSciences (CHRS) United States $1.510B 0.00
Gossamer Bio (GOSS) United States $1.508B 0.00
Cambrex (CBM) United States $1.484B 18.77
Innoviva (INVA) United States $1.438B 3.98
Epizyme (EPZM) United States $1.360B 0.00
Fate Therapeutics (FATE) United States $1.297B 0.00
Alector (ALEC) United States $1.253B 0.00
Aimmune Therapeutics (AIMT) United States $1.250B 0.00
Orchard Therapeutics Sponsored ADR (ORTX) United Kingdom $1.214B 0.00
Momenta Pharmaceuticals (MNTA) United States $1.207B 0.00
Athenex (ATNX) United States $1.203B 0.00
Sangamo Therapeutics (SGMO) United States $1.148B 0.00
Editas Medicine (EDIT) United States $1.124B 0.00
Rubius Therapeutics (RUBY) United States $1.095B 0.00
RA PHARMCTL INC (RARX) United States $1.079B 0.00
Dicerna Pharmaceuticals (DRNA) United States $1.059B 0.00
Codexis (CDXS) United States $1.050B 0.00
G1 THERAPEUTICS (GTHX) United States $1.045B 0.00
Deciphera Pharmaceuticals (DCPH) United States $1.001B 0.00
Atara Biotherapeutics (ATRA) United States $0.993B 0.00
Eidos Therapeutics (EIDX) United States $0.990B 0.00
Twist Bioscience (TWST) United States $0.976B 0.00
Alder BioPharmaceuticals (ALDR) United States $0.969B 0.00
CORTEXYME INC (CRTX) United States $0.963B 0.00
ZIOPHARM Oncology Inc (ZIOP) United States $0.959B 0.00
ANI Pharmaceuticals (ANIP) United States $0.928B 16.46
NGM Biopharmaceuticals (NGM) United States $0.911B 0.00
WAVE Life Sciences (WVE) Singapore $0.897B 0.00
Principia Biopharma (PRNB) United States $0.859B 0.00
Inotek Pharmaceuticals (RCKT) United States $0.852B 0.00
Retrophin (RTRX) United States $0.847B 0.00
Cara Therapeutics (CARA) United States $0.820B 0.00
Vericel (VCEL) United States $0.805B 0.00
Axsome Therapeutics (AXSM) United States $0.805B 0.00
Clovis Oncology (CLVS) United States $0.797B 0.00
Y-mAbs Therapeutics (YMAB) United States $0.769B 0.00
GENFIT Unsponsored ADR (GNFT) France $0.764B 0.00
Rhythm Pharmaceuticals (RYTM) United States $0.758B 0.00
Kiniksa Pharmaceuticals (KNSA) Bermuda $0.758B 0.00
Vanda Pharmaceuticals (VNDA) United States $0.745B 35.15
Precision BioSciences (DTIL) United States $0.741B 0.00
Kura Oncology (KURA) United States $0.740B 0.00
Intra-Cellular Therapies (ITCI) United States $0.732B 0.00
Adverum Biotechnologies (ADVM) United States $0.727B 0.00
MeiraGTx Holdings (MGTX) United States $0.710B 0.00
Arvinas (ARVN) United States $0.708B 0.00
Stemline Therapeutics (STML) United States $0.695B 0.00
Zymeworks (ZYME) Canada $0.688B 0.00
Intellia Therapeutics (NTLA) United States $0.673B 0.00
Myovant Sciences (MYOV) United Kingdom $0.672B 0.00
Autolus Therapeutics Sponsored ADR (AUTL) United Kingdom $0.655B 0.00
Heska (HSKA) United States $0.650B 66.53
Zealand Pharma (ZEAL) Denmark $0.650B 7.59
Cytokineticsorporated (CYTK) United States $0.646B 0.00
Cellectis (CLLS) France $0.633B 0.00
Lexicon Pharmaceuticals (LXRX) United States $0.631B 0.00
Viking Therapeutics (VKTX) United States $0.577B 0.00
Anika Therapeutics (ANIK) United States $0.571B 19.51
Milestone Pharmaceuticals (MIST) Canada $0.552B 0.00
Magenta Therapeutics (MGTA) United States $0.545B 0.00
Puma Biotechnology (PBYI) United States $0.533B 0.00
ObsEva SA (OBSV) Switzerland $0.527B 0.00
Revance Therapeutics (RVNC) United States $0.514B 0.00
DBV Technologies (DBVT) France $0.504B 0.00
CytomX Therapeutics (CTMX) United States $0.496B 0.00
Sorrento Therapeutics (SRNE) United States $0.482B 0.00
BeyondSpring (BYSI) United States $0.477B 0.00
UROGEN PHARMA (URGN) United States $0.475B 0.00
Provention Bio (PRVB) United States $0.458B 0.00
Kodiak Sciences (KOD) United States $0.443B 0.00
Mesoblast (MESO) Australia $0.441B 0.00
Synthorx (THOR) United States $0.434B 0.00
Replimune (REPL) United States $0.427B 0.00
Krystal Biotech (KRYS) United States $0.421B 0.00
Arcus Biosciences (RCUS) United States $0.420B 0.00
MediciNova (MNOV) United States $0.418B 0.00
Agenus (AGEN) United States $0.403B 0.00
UNITY Biotechnology (UBX) $0.398B 0.00
BioDelivery Sciences (BDSI) United States $0.394B 0.00
ProQR Therapeutics (PRQR) Netherlands $0.389B 0.00
Prothena (PRTA) Ireland $0.388B 0.00
Achillion Pharmaceuticals (ACHN) United States $0.387B 0.00
Kaleido Biosciences (KLDO) $0.386B 0.00
Gritstone Oncology (GRTS) United States $0.385B 0.00
Scholar Rock Holding (SRRK) United States $0.383B 0.00
Adaptimmune Therapeutics (ADAP) United Kingdom $0.383B 0.00
Albireo Pharma (ALBO) United States $0.376B 0.00
Sinovac Biotech (SVA) China $0.371B 0.00
ResTORbio (TORC) United States $0.370B 0.00
AC Immune SA (ACIU) Switzerland $0.369B 23.74
Biofrontera AG Sponsored ADR (BFRA) Germany $0.364B 0.00
Stealth BioTherapeutics Sponsored ADR (MITO) United States $0.364B 0.00
Acorda Therapeutics (ACOR) United States $0.360B 6.35
AVROBIO (AVRO) United States $0.360B 0.00
PDL BioPharma (PDLI) United States $0.358B 8.54
NuCana Sponsored ADR (NCNA) United Kingdom $0.348B 0.00
LogicBio Therapeutics (LOGC) United States $0.344B 0.00
Senesco Technologies (ELOX) United States $0.337B 0.00
Merus (MRUS) Netherlands $0.324B 0.00
Kindred Biosciences (KIN) United States $0.323B 0.00
NEXTCURE INC (NXTC) United States $0.321B 0.00
PHASEBIO PHARMA (PHAS) United States $0.307B 0.00
Cyclerion Therapeutics (CYCN) United States $0.305B 0.00
AMAG Pharmaceuticals (AMAG) United States $0.303B 0.00
Evelo Biosciences (EVLO) United States $0.302B 0.00
Syros Pharmaceuticals (SYRS) United States $0.290B 0.00
Protagonist Therapeutics (PTGX) United States $0.281B 0.00
Geron (GERN) United States $0.276B 0.00
XBiotech (XBIT) United States $0.272B 0.00
Sutro Biopharma (STRO) United States $0.272B 0.00
Cellular Biomedicine (CBMG) United States $0.271B 0.00
Athersys (ATHX) United States $0.264B 0.00
Constellation Pharmaceuticals (CNST) United States $0.263B 0.00
Inovio Pharmaceuticals (INO) United States $0.257B 0.00
Dynavax Technologies (DVAX) United States $0.254B 0.00
Urovant Sciences (UROV) United States $0.250B 0.00
Xenon Pharmaceuticals (XENE) Canada $0.246B 0.00
Neothetics (EVFM) United States $0.245B 0.00
Spero Therapeutics (SPRO) United States $0.242B 0.00
Chiasma (CHMA) United States $0.240B 0.00
Synlogic (SYBX) United States $0.238B 0.00
Syndax Pharmaceuticals (SNDX) United States $0.234B 0.00
AXCELLA HEALTH (AXLA) United States $0.229B 0.00
Five Prime Therapeutics (FPRX) United States $0.227B 0.00
Abeona Therapeutics (ABEO) United States $0.227B 0.00
Kadmon Holdings (KDMN) United States $0.227B 0.00
Celcuity (CELC) United States $0.226B 0.00
Pieris Pharmaceuticals (PIRS) United States $0.224B 0.00
Kamada (KMDA) Israel $0.219B 8.52
Avid Bioservices (CDMO) United States $0.216B 0.00
MannKind (MNKD) United States $0.216B 0.00
Eiger BioPharmaceuticals (EIGR) United States $0.214B 0.00
Cerecor (CERC) United States $0.214B 0.00
Affimed (AFMD) Germany $0.213B 0.00
ADMA Biologics Inc (ADMA) United States $0.212B 0.00
ChromaDex (CDXC) United States $0.211B 0.00
Enochian BioSciences (ENOB) United States $0.211B 0.00
BICYCLE THERAPT (BCYC) United Kingdom $0.206B 0.00
Compugen (CGEN) Israel $0.203B 0.00
Mersana Therapeutics (MRSN) United States $0.198B 0.00
Arsanis (XFOR) United States $0.193B 0.00
Kala Pharmaceuticals (KALA) United States $0.190B 0.00
Aeglea BioTherapeutics (AGLE) United States $0.188B 0.00
IDEAYA BIOSCI (IDYA) United States $0.187B 0.00
Strongbridge Biopharma (SBBP) United States $0.180B 10.41
Gamida Cell (GMDA) Israel $0.180B 0.00
Dyadic (DYAI) United States $0.179B 0.00
Solid Biosciences (SLDB) United States $0.177B 0.00
EYEPOINT PHARMACEUTICALS, INC (EYPT) United States $0.175B 0.00
BioXcel Therapeutics (BTAI) United States $0.173B 0.00
Enzo Biochem (ENZ) United States $0.172B 0.00
Anavex Life Sciences (AVXL) United States $0.171B 0.00
OSMOTICA PHARM (OSMT) United States $0.170B 0.00
OvaScience (MLND) United States $0.164B 0.00
Mustang Bio (MBIO) United States $0.162B 0.00
Liquidia Technologies (LQDA) United States $0.159B 0.00
HOOKIPA PHARMA (HOOK) United States $0.159B 0.00
Axovant Sciences (AXGT) United States $0.156B 0.00
Cue Biopharma (CUE) United States $0.156B 0.00
Kezar Life Sciences (KZR) United States $0.153B 0.00
TREVI THERAPTCS (TRVI) United States $0.153B 0.00
Menlo Therapeutics (MNLO) United States $0.149B 0.00
Aduro Biotech (ADRO) United States $0.149B 0.00
APPLIED THERAPT (APLT) United States $0.147B 0.00
XOMA (XOMA) United States $0.145B 0.00
TOCAGEN INC (TOCA) United States $0.144B 0.00
Intec Pharma (NTEC) Israel $0.144B 0.00
Checkpoint Therapeutics (CKPT) United States $0.141B 0.00
Verastem (VSTM) United States $0.134B 0.00
Novavax (NVAX) United States $0.132B 0.00
Eton Pharmaceuticals (ETON) United States $0.131B 0.00
Nymox Pharmaceutical (NYMX) Canada $0.129B 0.00
Arbutus Biopharma (ABUS) Canada $0.125B 0.00
AVEO Pharmaceuticals (AVEO) United States $0.123B 0.00
Paratek Pharmaceuticals (PRTK) United States $0.123B 0.00
Erytech Pharma SA Sponsored ADR (ERYP) France $0.119B 0.00
Celyad SA (CYAD) Belgium $0.119B 0.00
Aptinyx (APTX) United States $0.117B 0.00
Tiziana Life Sciences Sponsored ADR (TLSA) United Kingdom $0.115B 0.00
Aptose Biosciences (APTO) Canada $0.113B 0.00
SESEN BIO, INC (SESN) United States $0.112B 0.00
Fortress Biotech (FBIO) United States $0.112B 0.00
Seres Therapeutics (MCRB) United States $0.110B 0.00
ASLAN Pharmaceuticals (ASLN) Singapore $0.109B 0.00
NantKwest (NK) United States $0.109B 0.00
Alcobra (ARCT) United States $0.105B 0.00
Equillium (EQ) United States $0.104B 0.00
INmune Bio (INMB) United States $0.101B 0.00
VBI Vaccines (VBIV) United States $0.099B 0.00
Corvus Pharmaceuticals (CRVS) United States $0.099B 0.00
Allena Pharmaceuticals (ALNA) United States $0.097B 0.00
Trevena (TRVN) United States $0.093B 0.00
Aridis Pharmaceuticals (ARDS) United States $0.092B 0.00
Selecta Biosciences (SELB) United States $0.092B 0.00
Catalyst Biosciences (CBIO) United States $0.088B 0.00
Brainstorm Cell Therapeutics (BCLI) United States $0.088B 0.00
Catabasis Pharmaceuticals (CATB) United States $0.087B 0.00
InflaRx (IFRX) Germany $0.084B 0.00
Pluristem Therapeutics (PSTI) Israel $0.082B 0.00
Idera Pharmaceuticals (IDRA) United States $0.077B 0.00
ANIXA BIOSCIENCES INC (ANIX) United States $0.076B 0.00
Merrimack Pharmaceuticals (MACK) United States $0.076B 0.00
Signal Genetics (MGEN) United States $0.075B 0.00
Verona Pharma American Depositary Share (VRNA) United Kingdom $0.073B 0.00
Unum Therapeutics (UMRX) United States $0.072B 0.00
Cohbar (CWBR) United States $0.071B 0.00
Orgenesis (ORGS) United States $0.070B 0.00
OVID THERAPEUTC (OVID) United States $0.070B 0.00
Spring Bank Pharmaceuticals (SBPH) United States $0.070B 0.00
VTv Therapeutics (VTVT) United States $0.069B 0.00
Applied Genetic Technologies (AGTC) United States $0.069B 38.00
ARAVIVE, INC (ARAV) United States $0.067B 0.00
Cocrystal Pharma (COCP) United States $0.067B 0.00
AquaBounty Technologies (AQB) United States $0.067B 0.00
Alimera Sciences (ALIM) United States $0.066B 0.00
Vaccinex (VCNX) United States $0.061B 0.00
Prima BioMed (IMMP) Australia $0.061B 0.00
NewLink Genetics (NLNK) United States $0.059B 0.00
Moleculin Biotech (MBRX) United States $0.057B 0.00
ScPharmaceuticals (SCPH) United States $0.056B 0.00
DiaMedica Therapeutics (DMAC) United States $0.055B 0.00
Zosano Pharma (ZSAN) United States $0.055B 0.00
Proteostasis Therapeutics (PTI) United States $0.055B 0.00
Ophthotech (ISEE) United States $0.054B 0.00
Curis (CRIS) United States $0.054B 0.00
Oncobiologics (OTLK) United States $0.054B 0.00
Eyenovia (EYEN) United States $0.053B 0.00
Organovo Holdings (ONVO) United States $0.052B 0.00
Hoth Therapeutics (HOTH) United States $0.051B 0.00
Apricus Biosciences (SEEL) United States $0.048B 0.00
Bellerophon Therapeutics (BLPH) United States $0.045B 0.00
Sunesis Pharmaceuticals (SNSS) United States $0.045B 0.00
Cidara Therapeutics (CDTX) United States $0.044B 0.00
AEterna Zentaris (AEZS) United States $0.044B 0.00
INNOVATE BIOPHARMACEUTICALS, INC (INNT) United States $0.043B 0.00
Aptevo Therapeutics (APVO) United States $0.043B 0.00
Entera Bio (ENTX) Israel $0.043B 0.00
Vascular Biogenics (VBLT) Israel $0.042B 0.00
BiondVax Pharmaceuticals (BVXV) Israel $0.039B 0.00
Clearside Biomedical (CLSD) United States $0.039B 0.00
Leap Therapeutics (LPTX) United States $0.039B 0.00
Aerpio Pharmaceuticals (ARPO) United States $0.038B 0.00
Evogene (EVGN) Israel $0.038B 0.00
Celsion (CLSN) United States $0.037B 0.00
VIVUS (VVUS) United States $0.036B 0.00
AZURRX BIOPHARM (AZRX) United States $0.036B 0.00
Oncolytics Biotech (ONCY) Canada $0.035B 0.00
Celldex Therapeutics (CLDX) United States $0.035B 0.00
Akari Therapeutics (AKTX) United Kingdom $0.034B 0.00
Anchiano Therapeutics Sponsored ADR (ANCN) Israel $0.033B 0.00
VistaGen Therapeutics (VTGN) United States $0.033B 0.00
Sienna Biopharmaceuticals (SNNA) United States $0.031B 0.00
Aytu Bioscience (AYTU) United States $0.031B 0.00
Edge Therapeutics (PDSB) United States $0.029B 0.00
Bionano Genomics (BNGO) United States $0.029B 0.00
Bison Capital Acquisition (XYN) China $0.028B 0.00
Caladrius Biosciences (CLBS) United States $0.027B 0.00
Sophiris Bio (SPHS) United States $0.025B 0.00
Rexahn Pharmaceuticals (REXN) United States $0.022B 0.00
GENPREX INC (GNPX) United States $0.022B 0.00
Adial Pharmaceuticals (ADIL) United States $0.020B 0.00
Fibrocell Science Inc (FCSC) United States $0.019B 0.00
Titan Pharmaceuticals (TTNP) United States $0.019B 0.00
TRACON Pharmaceuticals (TCON) United States $0.019B 0.00
Vical (VICL) United States $0.019B 0.00
ATyr Pharma (LIFE) United States $0.018B 0.00
Histogenics (HSGX) United States $0.018B 0.00
Pulmatrix (PULM) United States $0.018B 0.00
Novelion Therapeutics (NVLN) Canada $0.018B 0.00
OncoSec Medical (ONCS) United States $0.017B 0.00
Cleveland BioLabs (CBLI) United States $0.017B 0.00
MYOS RENS Technology (MYOS) United States $0.015B 0.00
Gemphire Therapeutics (GEMP) United States $0.013B 0.00
TrovaGene (TROV) United States $0.013B 0.00
Advaxis (ADXS) United States $0.012B 0.00
Prana Biotechnology (ATHE) Australia $0.012B 0.00
Aileron Therapeutics (ALRN) United States $0.012B 0.00
Soligenix (SNGX) United States $0.012B 0.00
Motif Bio Plc (MTFB) United States $0.011B 0.00
IMMURON LTD (IMRN) Australia $0.011B 0.00
Genetic Technologies (GENE) Australia $0.010B 0.00
RestorGenex (DFFN) United States $0.010B 0.00
Vital Therapies (IMUX) United States $0.010B 0.00
Dare Bioscience (DARE) United States $0.009B 0.00
Cyclacel Pharmaceuticals (CYCC) United States $0.009B 0.00
Flex Pharma (FLKS) United States $0.009B 0.00
Benitec Biopharma (BNTC) Australia $0.009B 0.00
Therapix Biosciences (TRPX) Israel $0.009B 0.00
Proteon Therapeutics (PRTO) United States $0.009B 0.00
Tenax Therapeutics (TENX) United States $0.008B 0.00
ARCA Biopharma (ABIO) United States $0.007B 0.00
Neuralstem (CUR) United States $0.007B 0.00
Cytori Therapeutics Inc (CYTX) United States $0.005B 0.00
Stellar Biotechnologies (EDSA) United States $0.005B 0.00
ContraVir Pharmaceuticals Inc (CTRV) United States $0.004B 0.00
Galena Biopharma (SLS) United States $0.004B 0.00
Cellect Biotechnology (APOP) Israel $0.003B 0.00
Bio-Rad Laboratories (BIO.B) United States $0.000B 0.00
Horizon Pharma Public (HZNP) Ireland $0.000B 0.00
MEREO BIOPHARMA (MREO) $0.000B 0.00